FALCONE, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 5.746
EU - Europa 1.477
AS - Asia 769
AF - Africa 63
SA - Sud America 47
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 8.106
Nazione #
US - Stati Uniti d'America 5.688
IT - Italia 682
SG - Singapore 318
IN - India 239
FI - Finlandia 161
CN - Cina 160
DE - Germania 147
SE - Svezia 140
UA - Ucraina 57
CA - Canada 50
RU - Federazione Russa 47
IE - Irlanda 45
TG - Togo 44
GB - Regno Unito 42
NL - Olanda 39
AR - Argentina 38
AT - Austria 24
ID - Indonesia 22
BG - Bulgaria 21
RO - Romania 16
BE - Belgio 15
FR - Francia 15
PL - Polonia 8
MX - Messico 6
MY - Malesia 6
BJ - Benin 5
ES - Italia 4
JP - Giappone 4
LT - Lituania 4
TR - Turchia 4
VN - Vietnam 4
ZA - Sudafrica 4
BR - Brasile 3
EC - Ecuador 3
EG - Egitto 3
IR - Iran 3
AL - Albania 2
BZ - Belize 2
CH - Svizzera 2
ET - Etiopia 2
EU - Europa 2
LV - Lettonia 2
MA - Marocco 2
NZ - Nuova Zelanda 2
SC - Seychelles 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
GR - Grecia 1
HK - Hong Kong 1
HR - Croazia 1
IL - Israele 1
IQ - Iraq 1
LK - Sri Lanka 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
TH - Thailandia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 8.106
Città #
Fairfield 999
Dearborn 515
Woodbridge 443
Ashburn 432
Seattle 406
Houston 359
Cambridge 323
Wilmington 284
Rome 256
Chandler 253
Singapore 227
Ann Arbor 199
Princeton 156
San Paolo di Civitate 156
Plano 122
Lawrence 100
Santa Clara 88
Millbury 74
Beijing 73
Boston 55
Helsinki 49
Dublin 45
Lomé 44
San Diego 42
Fremont 38
Andover 33
Federal 32
Milan 27
Falls Church 25
Toronto 24
Des Moines 22
Moscow 21
Norwalk 21
Sofia 21
Jakarta 20
New York 20
Ottawa 20
Falkenstein 19
Vienna 19
Naaldwijk 16
Brussels 15
Frankfurt am Main 14
Jacksonville 14
Mannheim 14
Dallas 13
Bremen 12
Hefei 11
London 11
Nanjing 11
San Mateo 11
Boardman 9
Kunming 9
Los Angeles 9
San Jose 9
Verona 9
Bühl 8
Monterotondo 8
Buffalo 7
Redwood City 7
Bologna 6
Centrale 6
Munich 6
Nanchang 6
Phoenix 6
Southend 6
Altofonte 5
Fasano 5
Jinan 5
Warsaw 5
Buenos Aires 4
Chicago 4
Haiphong 4
Hyderabad 4
Muizenberg 4
Naples 4
Torino 4
Amsterdam 3
Ankara 3
Auburn Hills 3
Baotou 3
Chengdu 3
Civitavecchia 3
Corsico 3
Laurel 3
Mexico City 3
Montréal 3
Provo 3
Redmond 3
Albano Laziale 2
Anconetta 2
Baie-D'Urfe 2
Bari 2
Belize City 2
Castel di Sangro 2
Cordova 2
Cormons 2
Cuneo 2
Desio 2
Fuzhou 2
Iztacalco 2
Totale 6.423
Nome #
Low-grade endotoxemia, gut permeability and platelet activation in community-acquired pneumonia 146
Impaired flow-mediated dilation in hospitalized patients with community-acquired pneumonia 126
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 125
Nursing home residence is associated with spread of Clostridium difficile ribotype 027 in central Italy 123
Lower mortality rate in elderly patients with community-onset pneumonia on treatment with aspirin 120
Septic bilateral pulmonary candidiasis successfully treated with anidulafungin therapy in two patients with peritoneal carcinomatosis 108
Cardiovascular complications and short-term mortality risk in community-acquired pneumonia 106
Platelet activation is associated with myocardial infarction in patients with pneumonia 105
Expanded CURB-65: A new score system predicts severity of community-acquired pneumonia with superior efficiency 104
Corticosteroid use and incident myocardial infarction in adults hospitalized for community-acquired pneumonia 104
Pneumonia in frail older patients: an up to date. 104
Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae 99
Cirrhotic patients are at risk for health care-associated bacterial infections. 97
Individualizing risk of multidrug-resistant pathogens in community-onset pneumonia 96
Hemostatic balance in patients with liver cirrhosis. report of a consensus conference 96
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 91
Assessment of risk factors for candidemia in non-neutropenic patients hospitalized in Internal medicine wards. a multicenter study 88
Candidaemia after heart valve replacement surgery. Recurrence as prosthetic valve endocarditis is an expected over one-year complication 87
Candidemia in patients with body temperature below 37°C and admitted to internal medicine wards. Assessment of risk factors 86
Testis sparing surgery for small testicular masses. Retrospective analysis of a multi-center cohort 85
A cluster of fulminant Clostridium difficile colitis in an intensive care unit in Italy 84
Risk factors and clinical outcomes of candidaemia in patients treated for Clostridium difficile infection 84
The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective survey 83
A predictive model of mortality in patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae 83
Retrospective case-control analysis of patients with staphylococcal infections receiving daptomycin or glycopeptide therapy 83
Acute bacterial skin and skin structure infections in internal medicine wards. old and new drugs 82
Nox2 up-regulation is associated with an enhanced risk of atrial fibrillation in patients with pneumonia 82
Role of aspirin in patients with septic shock. a complex and intriguing relationship 81
Risk factors and outcomes for bloodstream infections secondary to Clostridium difficile infection 81
An empirical broad spectrum antibiotic therapy in Healthcare-Associated infections improves survival in cirrhotics. A randomized trial 80
Is NOX2 upregulation implicated in myocardial injury in patients with pneumonia? 80
Clinical impact of broad-spectrum empirical antibiotic therapy in patients with healthcare-associated pneumonia: a multicenter interventional study. 77
null 77
Teicoplanin use and emergence of Staphylococcus haemolyticus: is there a link? 75
Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia. 75
Conservative medical therapy of prosthetic joint infections: retrospective analysis of an 8-year experience 75
Early, intermediate and late infectious complications after transcatheter or surgical aortic-valve replacement: a prospective cohort study 74
Clinical experience of anidulafungin for the treatment of patients with documented candidemia. 73
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 73
Predictors of mortality in non-neutropenic patients with invasive pulmonary aspergillosis. Does galactomannan have a role? 71
Surgical debridement with muscle flap transposition and systemic teicoplanin therapy for infected hip arthroplasty 71
Topical nystatin prophylaxis: a likely viable measure for reducing impact of candidemia in neurosurgical patients with early tracheostomy intubation 71
Candidemia Subsequent to Severe Infection Due to Clostridium difficile: Is There a Link? 70
Surveillance and management of multidrug-resistant microorganisms 69
Considerations for higher doses of daptomycin in critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia. 68
Reply to: "The possible role of anti-methicillin-resistant Staphylococus aureus antimicrobial agents in spontaneous bacterial peritonitis" 68
Invasive pulmonary aspergillosis in non-neutropenic patients: analysis of a 14-month prospective clinical experience 68
Low-grade endotoxemia and clotting activation in the early phase of pneumonia 68
Health care associated pneumonia: a new clinical entity. 68
Staphylococcus aureus bacteremia in patients with hematologic malignancies: a retrospective case-control study 67
Role of multidrug-resistant pathogens in health-care-associated pneumonia 67
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: A multinational pre-registered cohort study 67
In vitro activity of daptomycin against methicillin- and multi-resistant Staphylococcus haemolyticus invasive isolates carrying different mec complexes 67
Conservative medical therapy of infections following osteosynthesis: A retrospective analysis of a six-year experience 66
Changing Italian nosocomial-community trends and heteroresistance in Staphylococcus aureus from bacteremia and endocarditis. 66
Patient risk factors for outer membrane permeability and KPC-producing carbapenem-resistant Klebsiella pneumoniae isolation: results of a double case-control study. 65
Predicting the occurrence of embolic events: an analysis of 1456 episodes of infective endocarditis from the Italian Study on Endocarditis (SEI) 65
The ADA (age-d-dimer-albumin) score to predict thrombosis in SARS-CoV-2 65
Serious infections due to methicillin-resistant Staphylococcus aureus: an evolving challenge for physicians. 64
Ampicillin Plus Ceftriaxone Is as Effective as Ampicillin Plus Gentamicin for Treating Enterococcus faecalis Infective Endocarditis 63
MEDical wards Invasive Candidiasis ALgorithms (MEDICAL). Consensus proposal for management 63
Clinical and in vitro efficacy of colistin plus vancomycin and rifampin against colistin-resistant Acinetobacter baumannii causing ventilator-associated pneumonia 63
Streptococcus anginosus group disseminated infection: case report and review of literature. 61
Successful Ertapenem-Doripenem Combination Treatment of Bacteremic Ventilator-Associated Pneumonia Due to Colistin-Resistant KPC-Producing Klebsiella pneumoniae 60
Performance of PSI, CURB-65, and SCAP scores in predicting the outcome of patients with community-acquired and healthcare-associated pneumonia 60
Daptomycin plus trimethoprim/sulfamethoxazole combination therapy in post-neurosurgical meningitis caused by linezolid-resistant Staphylococcus epidermidis 59
Clonal Multidrug-Resistant Corynebacterium striatum Strains, Italy 59
CAP and HCAP are different? An unresolved question 58
Comparison of disease clusters in two elderly populations hospitalized in 2008 and 2010 57
Functional outcomes following immediate repair of penile fracture: a tertiary referral centre experience with 76 consecutive patients 57
A case of Lactobacillus casei bacteraemia associated with aortic dissection: is there a link? 56
ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients 56
Severe community onset healthcare-associated Clostridium difficile infection complicated by carbapenemase producing Klebsiella pneumoniae bloodstream infection. 56
Early identification of severe community-onset pneumonia in "frail elderly patient". 56
Simplified Equations Using Two Concentrations To Calculate Area under the Curve for Antimicrobials with Concentration-Dependent Pharmacodynamics: Daptomycin as a Motivating Example 56
Staphylococcus haemolyticus endocarditis: clinical and microbiologic analysis of 4 cases 55
Infections with VIM-1 metallo-{beta}-lactamase-producing enterobacter cloacae and their correlation with clinical outcome. 55
Variability of pharmacokinetic parameters in patients receiving different dosages of daptomycin: is therapeutic drug monitoring necessary? 55
Healthcare-associated pneumonia: a never-ending story. 55
Identification and management of invasive mycoses in internal medicine: a road-map for physicians 55
null 54
Worrisome Trend of New Multiple Mechanisms of Linezolid Resistance in Staphylococcal Clones Diffused in Italy 53
null 53
Hospitalization for pneumonia is associated with decreased 1-year survival in patients with type 2 diabetes results from a prospective cohort study 53
Corticosteroid use, myocardial injury and in-hospital cardiovascular events in patients with community-acquired pneumonia 53
Healthcare-associated pneumonia: Diagnostic criteria and distinction from community-acquired pneumonia 52
null 52
Invasive aspergillosis in patients with liver disease 52
Spread of hypervirulent multidrug-resistant ST147 Klebsiella pneumoniae in patients with severe COVID-19: an observational study from Italy, 2020-21 52
Healthcare-associated pneumonia and multidrug-resistant bacteria: Do we have a convincing answer? 51
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation 51
Class I integron-borne bla(VIM-1) carbapenemase in a strain of Enterobacter cloacae responsible for a case of fatal pneumonia. 50
null 49
Daptomycin serum levels in critical patients undergoing continuous renal replacement 48
null 48
The relationship between cardiac injury, inflammation and coagulation in predicting COVID-19 outcome 48
[Piperacillin-tazobactam in the treatment of severe nosocomial infections]. 47
Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian Study on Endocarditis 46
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study) 46
null 46
Totale 7.168
Categoria #
all - tutte 26.385
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.385


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.059 0 0 0 0 0 0 331 236 230 127 78 57
2020/2021742 53 74 33 41 23 43 16 56 113 218 60 12
2021/20221.371 20 85 141 44 164 29 37 159 110 94 207 281
2022/20231.253 270 362 63 114 112 96 20 50 84 7 50 25
2023/2024612 43 84 37 58 47 56 15 46 9 82 64 71
2024/2025567 65 66 104 59 137 132 4 0 0 0 0 0
Totale 8.519